<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260913071035N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-09-14</date_registration>
      <primary_sponsor>Zanjan University of Medical Sciences</primary_sponsor>
      <public_title>Comparing the effectiveness of compassion-focused therapy and acceptance and commitment therapy in people who have experienced emotional breakdown</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the Effectiveness of Compassion-Focused Group Therapy and Schema-Informed Acceptance and Commitment Group Therapy on Depression, Internalized Shame, Interpersonal Problems, Early Maladaptive Schemas, and Quality of Life in Individuals Who Have Experienced Romantic Relationship Dissolution: A Three-Arm Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-09-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/93260</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: After recruiting volunteers, the implementation process is as follows: Screening and initial assessment. Volunteers are assessed with a short interview and complete self-report questionnaires (pre-test). Those who meet the entry criteria are selected to enter the random assignment stage.
In the next step, random assignment is performed. The random assignment sequence is generated using the RAND function in Excel software and simple randomization. In one column, 15 numbers code 1 (compassion-focused therapy group), 15 numbers code 2 (schema-aware acceptance and commitment therapy), and 15 numbers code 3 (control group) are entered, and 45 random numbers are generated in the adjacent column with the RAND function. The data is sorted in descending order based on the random number column, and the order of codes 1, 2, and 3 is determined completely randomly. This sequence is stored in an encrypted file.An independent researcher who has no role in administering the treatment generates the sequence and announces each participant's allocation code after they enter the study. Thus, the principal investigator who enters the participants into the study is unaware of the allocation sequence, Blinding description: Blinding Procedures in This Study

Due to the nature of the group-based psychological interventions, full blinding of all parties involved was not feasible. The blinding status of each role is described below:

Participants: Not blinded. Each participant was aware from the outset of their allocation to one of the two active intervention groups (Compassion-Focused Group Therapy or Schema-Informed Acceptance and Commitment Therapy) or to the waitlist control group, as the nature of group-based treatment (attendance versus non-attendance at sessions) precluded participant blinding. All participants, including those in the waitlist control group, were informed during the informed consent process, prior to enrollment, that they would be randomly allocated to one of three groups.
Principal Investigator: Not blinded. The principal investigator became aware of group allocation after the randomization process, given responsibility for coordinating intervention delivery. However, the principal investigator had no role in generating the randomization sequence (this was delegated to an independent researcher) and had no involvement in outcome assessment at post-test or follow-up, to prevent influence on results.
Therapists (intervention delivery personnel): Not blinded. The therapists (the principal investigator's student and a clinical psychology graduate student) were necessarily aware of the treatment protocol they delivered but had no role in outcome data collection or statistical analysis.
Data collectors and outcome assessors: Blinded. The outcome assessor was an individual independent of the therapy team and the principal investigator, responsible for conducting the structured clinical interview (SCID) and administering self-report questionnaires at post-test and 6-month follow-up. This individual did not attend therapy sessions, had no access to the randomization allocation file, and participants were instructed to refrain from disclosing their group assignment or session content to the assessor.
Statistical analyst: Blinded. Data were labeled with de-identified numeric codes (without group names or intervention type) prior to being provided to the statistical analyst. Primary analyses were conducted without knowledge of the correspondence between codes and group names; the decoding key was released to the analyst only after completion of the primary analyses.
Data Safety and Monitoring Board (DSMB): Given the small scale of this trial (single-center, limited sample size) and the low-risk nature of the psychological interventions, a formal DSMB was not established; safety and procedural oversight was instead conducted by the faculty supervisor and the university research ethics committee. [If a DSMB exists in your actual study, its blinding status must be reported in the same manner.]
Manuscript preparers: During preparation of the final report and descriptive analysis, the authors had access to the correspondence between codes and group names, as interpretation of findings required knowledge of intervention type. However, the primary (hypothesis-driven) statistical analyses were conducted and reported by the independent analyst prior to unblinding, to prevent biased interpretation.

Important ethical note: All participants, including those in the waitlist control group, were fully informed—prior to enrollment—of the study's research nature, the possibility of not receiving active treatment during the study period, and the guarantee of receiving effective treatment after study completion, and provided written informed consent. At no stage were participants left unaware of their participation in the research.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Individuals with a history of romantic relationship failure and depression.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention 1: Compassion-Focused Group TherapyAn 8-session weekly group protocol (90 minutes/session) based on The Compassionate Mind Workbook (Irons &amp; Beaumont), aimed at reducing internalized shame and depression through cultivating self-compassion and reducing self-criticism. Intervention 2: Intervention 2: Schema-Informed Acceptance and Commitment Therapy A 10-session weekly group protocol (90minutes/session) based on the Ciarrochi program, combining core ACT processes (acceptance, cognitive defusion, values) with identification of early maladaptive schemas, aimed at increasing psychological flexibility. Intervention 3: Control group: This group receives no active therapeutic intervention during the study period (including the intervention phase and the 6-month follow-up) and only completes the study questionnaires (Beck Depression Inventory, Internalized Shame Scale, Young Schema Questionnaire, Inventory of Interpersonal Problems, and SF-12 Quality of Life questionnaire) at pre-test, post-test, and 6-month follow-up assessments. Upon completion of the follow-up phase, participants in this group will receive whichever of the two active treatments is found to be more effective.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Given the sensitivity of the psychological data collected (including scores on depression, internalized shame, and maladaptive schemas) and the relatively small sample size of this study (n=45) conducted within a geographically limited population (Zanjan Province), there is a meaningful risk of participant re-identification even after removal of direct identifiers. Furthermore, the informed consent obtained from participants does not include explicit authorization for the public sharing of individual participant data (IPD) with external researchers. Accordingly, there is currently no plan to make the individual participant data from this study publicly available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyyede Elnaz Mousavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Dr. Beheshti Hospital, Darvazeh Arg, Zanjan</address>
        <city>Zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۴۵۱۳۶۱۵۷۸۸</zip>
        <telephone>+98 24 3354 4001</telephone>
        <email>elnaz48.mousavi@gmail.com</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Seyyede Elnaz Mousavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Zanjan, Darvazeh Arg, Shahid Dr. Beheshti Hospital</address>
        <city>Zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۴۵۱۳۶۱۵۷۸۸</zip>
        <telephone>+98 24 3354 4001</telephone>
        <email>elnaz48.mousavi@gmail.com</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. Score above the cutoff point (16) on the Post-Breakup Distress Scale.
2. Duration of the relationship at least 3 months before the breakup.
3. Experience of emotional breakdown in the past 6 months.
4. Having sufficient literacy to complete the questionnaires.
5. Age range 18 to 40 years.
6. Not receiving concurrent psychological treatment.
7. Score at least 14 on the Beck Depression Inventory (BDI-II)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Receiving psychotherapy or other psychological intervention at the start of the study
Experiencing a severe stressful event (such as bereavement or a serious accident) or having an acute medical illness (such as a heart attack or stroke)
Having severe symptoms of depression or suicidal thoughts that require immediate intervention
Failure to cooperate at any stage of the research or failure to complete the questionnaires</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F43.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Adjustment disorders</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention 1: Compassion-Focused Group TherapyAn 8-session weekly group protocol (90 minutes/session) based on The Compassionate Mind Workbook (Irons &amp; Beaumont), aimed at reducing internalized shame and depression through cultivating self-compassion and reducing self-criticism</i_keyword>
      <i_keyword>Intervention 2: Schema-Informed Acceptance and Commitment Therapy A 10-session weekly group protocol (90minutes/session) based on the Ciarrochi program, combining core ACT processes (acceptance, cognitive defusion, values) with identification of early maladaptive schemas, aimed at increasing psychological flexibility.</i_keyword>
      <i_keyword>Control group: This group receives no active therapeutic intervention during the study period (including the intervention phase and the 6-month follow-up) and only completes the study questionnaires (Beck Depression Inventory, Internalized Shame Scale, Young Schema Questionnaire, Inventory of Interpersonal Problems, and SF-12 Quality of Life questionnaire) at pre-test, post-test, and 6-month follow-up assessments. Upon completion of the follow-up phase, participants in this group will receive whichever of the two active treatments is found to be more effective.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Depression. Timepoint: Before the start of the intervention, after the completion of the intervention, and 6 months after the end of the intervention. Method of measurement: Depression:Measured using the Beck Depression Inventory-Second  Edition (BDI-II); the Persian version was validated by Ghassemzadeh et al. (2005).</prim_outcome>
      <prim_outcome>Interpersonal problems. Timepoint: Before the start of the intervention, after the completion of the intervention, and 6 months after the end of the intervention. Method of measurement: Interpersonal Problems:Measured using the short-form Inventory of Interpersonal Problems (IIP-32); the Persian version was validated by Fath et al. (2013).</prim_outcome>
      <prim_outcome>Early maladaptive schemas. Timepoint: Before the start of the intervention, after the completion of the intervention, and 6 months after the end of the intervention. Method of measurement: Early Maladaptive Schemas:Measured using the Young Schema Questionnaire-Short Form, 75 items (YSQ-SF); the Persian version was validated by Ghahari et al. (2020).</prim_outcome>
      <prim_outcome>Internalized shame. Timepoint: Before the start of the intervention, after the completion of the intervention, and 6 months after the end of the intervention. Method of measurement: Internalized Shame:Measured using Cook's Internalized Shame Scale (ISS); the Persian version was validated by Rajabi and Abbasi (2011).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Quality of life. Timepoint: Before the start of the intervention, after the completion of the intervention, and 6 months after the end of the intervention. Method of measurement: Measured using the 12-item Short Form Health Survey (SF-12).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Zanjan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-08-31</approval_date>
        <contact_name>Ethics Committee of Zanjan University of Medical Sciences</contact_name>
        <contact_address>Zanjan, Ostad Dr. Yousef Sobouti Boulevard, Zanjan University of Medical Sciences zanjan Zanjan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
